692
Can. J. Chem. Vol. 92, 2014
349.0930. Crystal data for 1: C17H13N2BF2O2, MM = 326.11 g/mol,
dark red needle, 0.90 mm × 0.33 mm × 0.15 mm; primitive tri-
clinic, space group P1 (#2), a = 7.5380(7) Å, b = 7.8407(7) Å, c =
13.3682(7) Å,  = 77.62(4)°, V = 740.0(2) Å3, Z = 2, = 1.463 g/cm3,
BF3·OEt2 followed by distilled water and then brine. The organic
solvent volume was then reduced in vacuo, and the compound
was purified using column chromatography (silica – 2% Et2O/hex-
anes). Removal of the organic solvent in vacuo gave the title com-
pound as a red/orange solid (106 mg, 16% yield). Upon NMR
analysis, it was noted that the compound was not pure. Purifica-
tion was attempted via column chromatography (silica – 10%
EtOAc/hexanes, alumina – 10% DCM/hexanes): these attempts
proved to be unsuccessful and the sample was used without fur-
(MoK␣) = 1.127 cm−1, 53727 reflections (20535 unique, Rint
0.029), R(F) = 0.0350, Rw(F) = 0.0487, GOF = 0.933; CCDC 949267.
=
4,4-Difluoro-8-(4-trifluoromethylphenyl)-4-bora-3a,4a-diaza-s-
indacene (7)
Using GP2, the title compound was synthesized from 5-(4-
trifluoromethyl)phenyldipyrromethane (300 mg, 1.03 mmol). The
title compound was isolated as a red solid (166 mg, 48% yield) after
column chromatography (silica – 20% Et2O/hexanes). 1H NMR
(500 MHz, CDCl3) ␦: 7.94 (s, 2H), 7.77 (d, 2H, J = 8), 7.65 (d, 2H, J = 8),
6.83 (d, 2H, J = 4), 6.53 (d, 2H, J = 4). 13C NMR (125 MHz, CDCl3) ␦:
145.2, 137.4, 134.9, 132.9, 132.7, 131.6, 130.8, 130.1, 125.7, 119.3.
11B{1H} NMR (160 MHz, CDCl3) ␦: 1.20 (t, J = 27.5). HRMS-ESI (m/z):
[M + Na]+ calcd. for C16H10B1F5N2O2Na: 359.0755; found: 359.0749.
1
ther purification. H NMR (500 MHz, CDCl3) ␦: 7.45–7.50 (m, 5H),
6.42 (s, 2H), 3.09 (t, 4H), 2.50 (t, 4H), 1.83–1.88 (m, 4H), 1.71–1.76 (m,
4H). 13C NMR (125 MHz, CDCl3) ␦: 157.5, 141.1, 134.8, 133.9, 130.4,
129.7, 129.4, 129.3, 128.2, 126.6, 24.8, 23.3, 23.0, 22.5. 11B{1H} NMR
(160 MHz, CDCl3) ␦: 0.58 (t, J = 32.6). HRMS-ESI (m/z): [M + Na]+ calcd.
for C23H23B1F2N2Na: 399.1820; found: 399.1815.
General procedure (GP3) for the microwave-assisted
deprotection and reduction of F-BODIPYs
F-BODIPY (50 mg) was added to a solution of NaOMe (3 equiv.)
and ethylene glycol (3 mL). The reaction mixture was degassed by
bubbling with N2 for 15 mins, and then it was then heated and
stirred at 215 °C for 10 min in a Biotage microwave system. The
reaction mixture was dissolved in DCM (50 mL) and washed with
water (50 mL × 3). The organic layer was dried with anhydrous
Na2SO4, concentrated, and purified via column chromatography
(alumina) to give a semisolid.
4,4-Difluoro-1,3,5,7-tetramethyl-2,6-di-3-hydroxypropyl-4-bora-
3a,4a-diaza-s-indacene (14)
Using GP1, the title compound was synthesized from 1,3,7,9-
tetramethyl-2,8-di(hydroxypropyl)-dipyrrin·HCl (450 mg, 1.29 mmol) in
3 h. The title compound was isolated as a red solid (90 mg, 18% yield)
1
after column chromatography (silica – 5% MeOH/DCM). H NMR
(500 MHz, CDCl3) ␦: 6.92 (s, 1H), 3.62 (t, 4H), 2.46 (s, 6H), 2.43 (t, 4H),
2.14 (s, 6H), 1.64–1.70 (m, 4H), 1.24 (br s, 2H). 13C NMR (125 MHz,
CDCl3) ␦: 155.6, 137.9, 133.0, 129.8, 119.4, 62.7, 33.4, 20.7, 13.2, 10.2.
11B{1H} NMR (160 MHz, CDCl3) ␦: 0.86 (t, J = 34.2). HRMS-ESI (m/z):
[M + Na]+ calcd. for C19H27B1F2N2O2Na: 387.2031; found: 387.2026.
5-((4-(2-Hydroxy)ethoxycarboxy)phenyl)dipyrromethane (3)
Using GP3, the title compound was synthesized from 4,4-
difluoro-8-(4-methoxycarbonylphenyl)-4-bora-3a,4a-diaza-s-indacene (1).
The title compound was isolated as a dark semisolid (29 mg, 68%
yield) after column chromatography (alumina − 0%–10% MeOH/
DCM). 1H NMR (500 MHz, CDCl3) ␦: 8.12 (s, 2H), 7.99 (d, 2H, J = 8),
7.29 (d, 2H, J = 8), 6.72 (s, 2H), 6.15 (quintet, 2H), 5.88 (s, 2H), 5.53 (s,
1H), 4.45 (t, 2H), 3.95 (t, 2H). 13C NMR (125 MHz, CDCl3) ␦: 166.9,
147.9,131.7, 130.1, 128.60, 128.56, 117.7, 108.6, 107.6, 66.7, 61.4, 44.1.
HRMS-ESI (m/z): [M + Na]+ calcd. for C18H18N2O3Na: 333.1215; found:
333.1210.
indacene (15)46
Using GP1, the title compound was synthesized from 1,3,7,9-
tetramethyl-2,8-di(hydroxypropyl)-dipyrrin·HBr (250 mg, 0.59 mmol) in
4 h. The title compound was isolated as a red solid (122 mg, 71% yield)
1
after column chromatography (silica–DCM). H NMR (500 MHz,
CDCl3) ␦: 6.94 (s, 1H), 2.48 (s, 6H), 2.34 (t, 4H), 2.15 (s, 6H), 1.40–1.46
(m, 4H), 1.27–1.36 (m, 8H), 0.90 (t, 6H). 13C NMR (125 MHz, CDCl3) ␦:
155.0, 137.1, 132.6, 130.4, 118.7, 31.8, 30.0, 24.2, 22.7, 14.2, 12.8, 9.7.
11B{1H} NMR (160 MHz, CDCl3) ␦: 0.76 (t, J = 34.6). HRMS-ESI (m/z):
[M + Na]+ calcd. for C23H35B1F2N2Na: 411.2759; found: 411.2754.
5-Phenyldipyrromethane (5)
Using GP3, the title compound was synthesized from 4,4-difluoro-
8-phenyl-4-bora-3a,4a-diaza-s-indacene (4). The title compound
was isolated as a dark beige solid (28 mg, 68% yield) after column
chromatography (alumina − 10% Et2O/hexanes). 1H NMR (500 MHz,
CDCl3) ␦: 7.93 (br s, 1H), 7.20–7.35 (m, 5H), 6.70 (d, 2H, J = 6), 6.17 (d,
2H, J = 7) 5.92 (d, 2H, J = 6), 5.48 (s, 1H). Data comparable with
previously reported data.40
4,4-Difluoro-1,3,5,7-tetramethyl–2,6-diethyl-8-
(4-methoxycarbonylphenyl)-4-bora-3a,4a-diaza-s-indacene (19)51
Using GP2, the title compound was synthesized from 1,3,7,9-
tetramethyl-2,8-diethyl-5-(4-methoxycarbonylphenyl)dipyrromethane
(2.39 g, 6.10 mmol) stepwise. Following GP2, the dipyrrin formed
in 45 min and was converted to the BODIPY in an additional 2 h.
The title compound was isolated as a dark green solid (589 mg,
5-(4-Trifluoromethylphenyl)dipyrromethane
Using GP3, the title compound was synthesized from 4,4-difluoro-
8-(4-trifluoromethylphenyl)-4-bora-3a,4a-diaza-s-indacene (7). The
title compound was isolated as a dark beige semisolid (21 mg,
53% yield) after column chromatography (alumina−DCM). 1H NMR
(500 MHz, CDCl3) ␦: 7.97 (s, 2H), 7.59 (d, 2H, J = 8), 7.35 (d, 2H, J = 8),
6.74 (s, 2H), 6.17 (s, 2H), 5.53 (s, 1H). Data comparable with previ-
ously reported data.56
1
22% yield) after column chromatography (silica–DCM). H NMR
(500 MHz, CDCl3) ␦: 8.17 (d, 2H, J = 8), 7.40 (d, 2H, J = 8), 3.98 (s, 3H),
2.53 (s, 6H), 2.29 (q, 4H), 1.25 (s, 6H), 0.98 (t, 6H). 13C NMR (125 MHz,
CDCl3) ␦: 166.7, 154.4, 140.8, 138.8, 138.2, 133.2, 130.7, 130.4, 128.8,
52.5, 17.2, 14.7, 12.7, 12.0. 11B{1H} NMR (160 MHz, CDCl3) ␦: 0.65 (t,
J = 33.3). HRMS-ESI (m/z): [M + Na]+ calcd. for C25H29B1F2N2Na:
461.2188; found: 461.2182.
5-(4-Methylphenyl)dipyrromethane
5,5-Difluoro-11-phenyl-5-bora-4b,5adiaza-s-1,2,3,4,6,7,8,9-
octahydroindeno[2,1-b]fluorene (20)
Using GP3, the title compound was synthesized from 4,4-difluoro-
8-(4-methylphenyl)-4-bora-3a,4a-diaza-s-indacene (8). The title
compound was isolated as a dark beige solid (26 mg, 63% yield)
after column chromatography (alumina − 5%–10% EtOAc/hex-
anes). 1H NMR (500 MHz, CDCl3) ␦: 8.00 (s, 2H), 7.26 (d, 2H, J = 9),
6.80 (s, 2H), 6.30 (q, 2H), 6.06 (s, 2H), 5.56 (s, 1H), 2.49 (s, 3H). Data
comparable with previously reported data.40
Tetrahydroindole (429 mg, 3.54 mmol) and benzoyl chloride
(205 L, 1.77 mmol) were heated and stirred at reflux temperature
in anhydrous dichloroethane (55 mL) for 48 h. The solution was
allowed to cool to room temperature, and then the in situ gener-
ated dipyrrin was treated with 6 equiv. of NEt3 and 9 equiv. of
BF3·OEt2. Upon consumption of the dipyrrin (monitored via TLC,
1 h), the solvent was removed from the reaction mixture in vacuo.
The crude dark red solid was dissolved in diethyl ether and
washed twice with 1 mol/L HCl (equal parts) to remove excess
5-(4-Methoxyphenyl)dipyrromethane
Using GP3, the title compound was synthesized from 4,4-difluoro-
8-(4-methoxyphenyl)-4-bora-3a,4a-diaza-s-indacene (9). The title
Published by NRC Research Press